Skip to content

BHIVA: No clinical difference seen in first-line treatment response between B and non-B subtypes

Tropism test could show which patients would benefit from starting HIV treatment sooner

Breath test could monitor adherence to treatment, potential use for DOTS and clinical trials

Southern African HIV Clinicians' Society: new treatment guidelines

ART recommended for all with CD4 counts below 350, say South African doctors

Unexpected drug interaction found between Kaletra and rosuvastatin

Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows